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In a recent issue of EHP Zhang and Pan 
(2009) reported on the effects of the explosive 
hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) 
on the differential expression of microRNAs 
(miRNAs) in brain and liver of B6C3F1 mice. 
It is always of interest when new technologies 
are applied to existing toxi  cologic problems, 
with a view to increasing our understanding 
of the effect on, or risk to, humans. However, 
in the abstract of their article originally pub-
lished online (but deleted from the final ver-
sion), Zhang and Pan (2009) concluded that 
“environmental toxicant exposure alters the 
expression of a suite of miRNAs that in turn 
regulates gene expression which may lead to 
carcino  genesis, developmental, neuronal, and 
reproductive toxicity”; they reached this con-
clusion in the absence of any observations 
for dose response, clinical chemistry, histo-
pathology, or neurotoxicity. Because their 
results do not support these conclusions, we 
felt a response was warranted. 
Zhang and Pan (2009) exposed B6C3F1 
female mice to RDX in food. The mouse 
chow was sprayed with a solution of acetone- 
dissolved RDX and allowed to dry; this 
resulted in a formulation chow containing 
5 mg RDX/kg of food. At this dose of RDX, 
we estimated that the mice received approxi-
mately 0.75–1.5 mg/kg body weight/day, 
based on mouse food consumption of 3–6 g/
day and an average body weight of 20 g. To 
put this dose in perspective, the 2-year can-
cer study on which RDX risk assessment was 
based (Lish et al. 1984) used oral doses of 0, 
1.5, 7.0, 35, and 175 mg RDX/kg/day in the 
same mouse strain, with statistically signifi-
cant liver cancers found only in the 35-mg/
kg dose group. The dose used by Zhang and 
Pan in their 1-month study was therefore 
less than the lowest dose in the 2-year mouse 
cancer study and over 20 times lower than 
the only dose of RDX associated with can-
cer. Furthermore, given that only a fraction 
of the exposed animals developed cancer at 
the 35-mg/kg dose in the 2-year study (Lish 
et al. 1984), we wonder how let-7 and other 
miRNAs used by Zhang and Pan (2009) 
identify which animals could potentially get 
cancer at a higher dose (i.e. susceptibility), 
or whether all animals could develop cancer 
even at this low dose (i.e., over  prediction).
At high oral exposures, RDX causes tonic–
clonic seizure, an effect that has been well cor-
related with internal dose (blood RDX was 
not measured in Zhang and Pan’s study). 
The mode of action of RDX is thought to 
be direct because seizures can occur within 
minutes of dosing. Zhang and Pan (2009) 
reported that brain derived miRNA 206 was 
increased 26-fold and brain-derived neuro-
trophic factor (BDNF) was computationally 
identified as a downstream target, with the 
direction of change presumably inhibitory on 
BDNF. Current literature shows that BDNF 
is actually up-regulated in response to seizure-
inducing agents, such as kainite (Revuelta et al. 
2005) and domoic acid (Doucette et al. 2004). 
Whether other presumed targets of miRNA 
would be up-regulated is not known, making 
verification of miRNA targets (mRNA) critical 
in the validation of this kind of study.
Although miRNAs have been used exten-
sively to examine the profiles of small RNAs 
in distinct phenotypes such as cancer, their 
significance as predictors of toxic insult or 
disease has not been demonstrated. The field 
of miRNAs is burgeoning with publications 
(1,738 in 2008), many of which involve the 
retro  spective examination of diseased tissue 
(tumors) for changes in the expression of 
miRNA species. Prospective work relating 
chemical exposure to changes in miRNA 
as predictors of imminent disease has been 
less successful, and a study of dioxin found   
miRNAs refractive (Moffat et al. 2007). 
More important, some reviews (Kozak 2008) 
caution against over  interpretation of miRNA 
data, especially without verification of down-
stream targets. 
It has been said that “a difference, to 
be a difference, should make a difference.” 
We found it difficult to assess the biologi-
cal significance of the suite of differentially 
regulated miRNAs and their computational 
targets culled from the study of Zhang and 
Pan (2009); although these miRNAs could 
be associated with exposure to RDX, they do 
not seem related to disease. In our opinion, 
Zhang and Pan’s results fall short of their 
experimental hypothesis that exposure to spe-
cific environmental agents, such as RDX, 
would cause alteration in miRNA expres-
sion and that “the altered miRNA expression 
contributes to carcinogenesis.” For innovative 
work of this kind, a solid model of exposure–
disease is always a good starting point, cou-
pled with the classical toxicology stalwarts 
of dose response and positive/negative con-
trols, and of course, verification of putative 
targets. Here, we feel that poor study design, 
absence of phenotype, and over  interpreation 
of data significantly weakened a potentially 
  informative body of work. 
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RDX and miRNA Expression: 
Zhang and Pan Respond
doi:10.1289/ehp.0800276R
We appreciate the interests and comments 
from Bannon et al. regarding our recent   
article on RDX-induced aberrant microRNA 
(miRNA) expression in mice (Zhang and Pan 
2009). However, we disagree with their com-
ments based on the misunderstanding of our 
results and conclusions. 
The objective of our study (Zhang and 
Pan 2009) was not to use clinical chemis-
try and histo  pathological features to diagnose 
neoplasm and carcinogenesis, but to investi-
gate the effect of a low-dose RDX exposure 
on miRNA expression in mice. Our results 
show that exposure to RDX at 5 mg/kg in the 
diet for 28 days induced aberrant expression 
of miRNAs in B6C3F1 mice. Our discussion 
of the implications of altered miRNAs in the 
carcinogenic risk of RDX suggested by a pre-
vious study (Lish et al. 1984) are based on the 
knowledge that aberrant miRNA expression 
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is associated with a broad range of cancers 
(Zhang et al. 2007). Meanwhile, we also dis-
cussed the potential anti  cancer effects of RDX 
in our article. Results in our Figure 6 indicate 
that RDX exposure induced miR-206 expres-
sion, which may inhibit expression of TNKS 
(tankyrase, TRF1-interacting ankyrin-related 
ADP-ribose polymerase). The inhibition of 
TNKS causes telomere shortening and apop-
tosis, which inhibits carcinogenesis, and has 
thus been proposed as a potential cancer ther-
apy (Seimiya 2006). Thereby, the miR-206 
overexpression induced by RDX may provide 
a mechanism to prevent carcinogenesis. 
Animals are more sensitive to chemical 
exposure at the gene level than at the physio-
logic level, and gene expression profile is a 
more powerful predictor of the outcome of 
disease than standard systems based on clini-
cal and histologic criteria (van de Vijver et al. 
2002). However, aberrant gene expression 
may or may not cause carcinogenesis. Cancer 
patho  genesis is a complex process associated 
with aberrant expression of many genes. 
Recently identified miRNAs play critical 
roles in cancer development; over  expression 
or down-regulation of a single miRNA could 
influence cancer cell growth, invasion, and 
metastasis (Ma et al. 2007; Takamizawa 
et al. 2004). Also, more and more evidence 
demonstrates that environmental carcino-
gens cause aberrant expression of a suite of 
miRNAs. For example, Kalscheuer et al. 
(2008) recently demonstrated the differential 
expression of miRNAs in early-stage neo-
plastic transformation in the lungs of F344 
rats chronically treated with the tobacco 
carcinogen NNK (4-(methylnitrosamino)-
1-(3-pyridyl)-1-butanone). Thus, carcinogen-
induced aberrant expression of miRNAs may 
be associated with carcinogenesis. 
Brain-derived neuro  trophic factor 
(BDNF) is targeted by multiple miRNAs. 
Besides miR-206, two experimentally vali-
dated BDNF-targeting miRNAs, miR-30a 
and miR-195 (Mellios et al. 2008), were also 
significantly up-regulated in mouse brain 
after RDX exposure. Thus, it is reasonable 
to suggest that miRNA-mediated BDNF 
expression is a neuro  toxic effect of low RDX 
exposure, given that BDNF is an important 
neuro  trophin supporting neuronal survival 
and differentiation, neurite outgrowth, and 
synaptic plasticity. 
Seizures have been induced by RDX 
at high acute doses but not at low doses 
(Burdette et al. 1988; Schneider et al. 1978). 
Our result is similar to that in previous 
reports, and we observed no seizures in our 
study using low doses. Both pro  epileptogenic 
and anti  epileptogenic effects of BDNF have 
been reported (Binder et al. 2001); therefore, 
we did not discuss the potential inhibition of 
BDNF in the context of RDX-induced seizure 
in our article. However, the up-regulation of 
BDNF reported in most chemical-induced 
seizures have been meas  ured at post  seizure 
and post  lesion periods instead of pre  seizure 
periods (Binder et al. 2001; Nawa et al. 1995). 
Indeed, BDNF is naturally down-expressed in 
chronic epileptic stages (Shetty et al. 2003), 
and the reduced level of BDNF may play 
important roles in the pro  excito  toxic effect of 
chronic stress (Mattson 2007). Neurotoxicants 
such as alcohol (Fattori et al. 2008) and poly-
brominated diphenyl ethers (Viberg et al. 
2008) also inhibit BDNF expression. Alcohol 
has also been found to increase miR-335 
expression at low doses but suppress miR-
335 at high doses, suggesting some miRNAs 
respond to neuro  toxicants in a dose-specific 
manner (Sathyan et al. 2007).
Our study (Zhang and Pan 2009) pro-
vides substantial information on miRNA 
expression as a phenotype in response to 
RDX exposure in mice. We reported many 
important novel findings that enlighten future 
research. For example, miR-206—belonging 
to the same family as miR-1, which regulates 
signal transduction at neuro  muscular junc-
tions (Simon et al. 2008)—was significantly 
up-expressed in our study. Therefore, eluci-
dating the role of miR-206 in RDX-related 
neurotoxicity is an enormous project. 
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Don’t Flush the Yuck Factor
doi:10.1289/ehp.0800542
I enjoyed Charles Schmidt’s original and infor-
mative article on the “Yuck Factor” (Schmidt 
2008). This phenomenon has come into play 
in my attempts to decide on whether to pur-
chase a low-flow toilet for my home. My city 
is currently offering rebates on low-flow toi-
lets, but only on the least consumptive models 
(1.6 gallons per flush). I have read on web sites 
and heard from friends that these models do 
not quite do the job. The details are important 
to me. If it is a question of not flushing gobs of 
toilet paper down, I can deal with that. But if 
these toilets leave stains on (or product in) the 
bowl, my family will not be happy. My discus-
sions with city officials and friends who have 
installed these toilets invariably break down 
when I press for details. The “Yuck Factor” 
reigns supreme. The end result may be that I 
do not purchase a low-flow toilet.
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